Home » Topics » BioWorld Science

BioWorld Science
RSS

Interim phase I data for ATOR-1015 presented by Alligator Bioscience

April 29, 2020

First prospective peek at Thrive's Cancerseek reveals gaps in liquid biopsy testing

April 29, 2020

Protein binder specific for hPD-1 shows strong antitumor activity in vivo

April 29, 2020

ABBV-951 shows promising safety in patients with Parkinson's disease

April 29, 2020

Regenacy Pharmaceuticals discloses new HDAC1/HDAC2 inhibitors

April 29, 2020

FDA clears IND application for CRX-100

April 29, 2020

Vicore receives regulatory approval to initiate phase II study of VP-01 in COVID-19

April 29, 2020

Topline data from phase III study of Dextenza in allergic conjunctivitis

April 29, 2020

Tetra Bio-Pharma to develop PPP-003 for management of CRS

April 29, 2020

Phase III VOYAGER study of avapritinib does not meet primary endpoint

April 29, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...